Discover our comprehensive range of pharmaceutical products designed to improve health outcomes across various therapeutic areas. Each product is developed with rigorous research and quality standards.
Kalmona-D3 Tablets are a pharmaceutical bone-health formulation designed to promote strong bones and a steady, active life. The formulation combines Calcium Citrate, Vitamin D3, and Ostium® CPP (Casein Phosphopeptides) with high CPP content (35%) to significantly enhance calcium absorption, improve bioavailability, and support optimal bone mineralization. This integrated mechanism helps reduce bone resorption and ensures efficient calcium utilization for long-term skeletal strength.
Maximeg-3 Syrup is a pharmaceutical formulation designed to support strength, mental clarity, and healthy aging. It combines Omega-3 fatty acids (EPA & DHA), Ginkgo Biloba Extract, and Vitamin D3 to promote optimal brain circulation, neuronal membrane integrity, and neuromuscular health. The formulation enhances cognitive performance, mental alertness, physical stability, and long-term neurological wellness.
Carnodale Plus Syrup is a pharmaceutical neurodevelopment support formulation specially designed for children aged 2 to 14 years. It combines L-Carnosine and DHA (Docosahexaenoic Acid) to provide long-lasting cognitive and behavioral benefits. The formulation supports antioxidant protection, synaptic communication, and healthy brain development, helping improve attention, behavior, cognition, and speech development in growing children.
Carnodale Syrup is a pharmaceutical neuroprotective formulation designed to support critical brain development pathways, particularly the amygdala. It contains L-Carnosine, a naturally occurring dipeptide found in brain and muscle tissue, known for its antioxidant, anti-glycation, and mitochondrial supportive actions. The formulation helps protect neurons from oxidative stress, supports neurotransmitter balance, and improves neuronal energy metabolism, contributing to better cognitive and behavioral outcomes.
Prazodoc-DSR Capsules are a dual-action pharmaceutical formulation designed for effective control of gastric acidity and enhanced digestive comfort. The combination of pantoprazole and domperidone works synergistically to suppress excess acid secretion, improve gastric motility, prevent acid reflux, and relieve associated symptoms such as heartburn, bloating, nausea, and indigestion. This formulation supports sustained relief in acid-related gastrointestinal disorders.
Bevrixa-50 Tablets are a pharmaceutical antiepileptic formulation designed for advanced control of partial-onset seizures. Containing brivaracetam, the formulation provides rapid and targeted seizure control by stabilizing abnormal neuronal firing and preventing seizure spread. Its high brain penetration and strong synaptic vesicle protein binding make it an effective option for patients requiring reliable seizure management.
Cerecura-P Tablets are a pharmaceutical cognitive support formulation designed to enhance memory, learning, and overall brain performance. The combination of Piracetam and Citicoline efficiently crosses the blood–brain barrier and works synergistically to support neuronal membrane integrity, neurotransmitter production, cerebral blood flow, and brain energy metabolism, resulting in improved mental clarity, focus, and cognitive efficiency.
Gabrionix ER-300 Tablets are a pharmaceutical formulation featuring a revolutionary gastro-retentive extended-release system that provides up to 24-hour pain control. The controlled gastric release of gabapentin allows sustained drug exposure, improved absorption, predictable dose proportionality, and faster achievement of therapeutic levels. This results in effective and well-tolerated management of neuropathic pain and seizure disorders.
Norpega-NT Tablets are a pharmaceutical multimodal formulation designed for effective management of peripheral neuropathic pain. The dual-action combination of pregabalin and nortriptyline targets both peripheral nerve hyperexcitability and central pain modulation, providing comprehensive relief in chronic neuropathic pain conditions while also improving sleep quality and overall patient comfort.
Q-ZAC Soft Gel Capsules are a pharmaceutical formulation designed to nourish the brain and support neurodevelopmental functions, with a focus on the amygdala and overall cognitive performance. The combination of Omega-3 Fatty Acids, Vitamin E, and Coenzyme Q10 supports neuronal membrane integrity, synaptic flexibility, antioxidant protection, and mitochondrial energy production. This multimodal action helps enhance learning, memory, motor coordination, sensory processing, and social behavior regulation.
Valproxa ER-500 Tablets are an extended-release pharmaceutical formulation of divalproex sodium, designed for effective seizure control and mood stabilization. The long-acting, once-daily formulation provides stable plasma levels, helping suppress seizure activity, stabilize neuronal firing, and support mood regulation. It is indicated for epilepsy, bipolar disorder, and migraine prevention.
Cartuff-II Tablets are a pharmaceutical formulation indicated for the management of osteoarthritis and various forms of arthritis. The formulation targets key pathological mechanisms such as inflammation, cartilage degradation, joint-space narrowing, and reduced synovial lubrication. By combining advanced bioactive extracts, collagen support, and hyaluronic acid, Cartuff-II helps reduce pain, improve joint mobility, and slow the progression of cartilage damage across different stages of osteoarthritis.
Myrafast Forte Tablets are a pharmaceutical formulation designed for multimodal pain relief, because every move matters. The formulation combines advanced anti-inflammatory, analgesic, and joint-supporting ingredients that act on multiple pain pathways, including COX-2, 5-LOX, CB-2, and μ-opioid receptors. This targeted mechanism helps reduce inflammation, relieve pain, and improve functional mobility with clinically observed improvements in pain scores and functional outcomes.
